As a consumer representative, I worry what placing a bulk substance on the list conveys in terms of FDA approval, said committee member Todd Durham, senior vice president of clinical outcomes and research at the Foundation Fighting Blindness, who voted no on adding these peptides to the list
These statistics are interpreted as similar likelihood that a randomly selected patient with high BSA involvement would have at least the same or greater impairment in quality of life and symptom burden as a randomly selected patient with medium BSA involvement (i.e., a randomly selected patient with high BSA will have the same or greater burden as a patient with medium BSA in 5259% of comparisons)
RRT is predominantly applied to treat severe AKI (grade 3)
treatment may impact areas of autism severity, verbal communication, expressive communication, personal daily living skills, coping skills, or socialization, for example